INSIDER · CIK 1565832
Traversa Sergio
Chief Executive Officer, Director at RELMADA THERAPEUTICS, INC. (RLMD)
↗1 Form 4 rows in the window
Covers original filings from Aug 1, 2026 to Oct 29, 2026. Older trades and amendments are in the SEC history.
$828KBought on the market
$0.00Sold on the market
1Companies
Sep 11, 2026Latest filing
| Company | Title | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 11, 202607:30 | Sep 10, 2026from Sep 9, 2026 | RLMDRELMADA THERAPEUTICS, INC. | Chief Executive Officer, Director | P · Buy | $4.14 | +200,000 | 1,500,000 | +15% | +$828K | -40.7% | -16.9% |